Humana Inc.

About Humana Inc.

Humana is a health insurance company with disclosed exposure to Medicare Advantage, serving members through that government-sponsored coverage and related operating programs such as Stars. It makes money from insurance premiums and associated healthcare activities, although the supplied evidence does not provide segment revenue contributions, customer counts, or a fuller product mix. Management’s current focus is improving Medicare Advantage margins in 2027 and advancing Stars performance. Humana reported FY2025 revenue of $5.8 billion and net income of $1.2 billion, versus $4.4 billion and $1.2 billion, respectively, in FY2024.

Notable Price Movement

1. Aug 3-7$362.160.47%

   The stock declined 6.83%, from $388.71 to $362.16 over the supplied window. The dominant move was a sharp $23.30 drop on July 29, followed by only modest stabilization: shares edged to $366.66 on July 30 and slipped to $363.86 on July 31. Humana then recovered to $374.50 on August 3 before giving back $12.34 the next session. The supplied company-specific commentary did not identify a miss or outlook cut: management said 2026 performance was tracking in line, while emphasizing 2027 Medicare Advantage margin expansion and Stars progress. With no dated catalyst or broader-market comparison provided, the decline cannot be attributed more precisely.

   2 sources

Stories & Analysis

CI Q2 Earnings Beat Estimates on Cigna Healthcare StrengthZacks · 6d agoHumana Q2 Earnings Call HighlightsMarketBeat · Jul 30Q2 Earnings Season in Full SwingZacks · Jul 29Humana Q2 Earnings Beat Estimates on Medical Membership GrowthZacks · Jul 29Investors Await Fed Decision TodayZacks · Jul 29Compared to Estimates, Humana (HUM) Q2 Earnings: A Look at Key MetricsZacks · Jul 29Humana (HUM) Q2 Earnings and Revenues Top EstimatesZacks · Jul 29Humana Inc Profit Climbs In Q2RTTNews · Jul 29